PRELIMINARY CLINICAL-RESULTS WITH TC-99M-MERCAPTOACETYLTRIGLYCINE (MAG3)

被引：0
|
作者：
NAGELEWOHRLE, B
GRIMM, W
VONWALLENBERG, H
RIEDMILLER, H
NICKEL, O
EISSNER, D
HAHN, K
机构：
[1] UNIV MAINZ KLINIKUM,NUKL MED ABT,D-6500 MAINZ 1,FED REP GER
[2] UNIV MAINZ KLINIKUM,UROL KLIN & POLIKLIN,D-6500 MAINZ 1,FED REP GER
来源：
NUKLEARMEDIZIN | 1988年 / 27卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [1] PARAMETRIC IMAGING OF THE KIDNEYS WITH TC-99M-MERCAPTOACETYLTRIGLYCINE (MAG3)
    SZABO, Z
    VOSBERG, H
    KUTKUHN, B
    GEORGESCU, G
    MECKLENBECK, W
    FEINENDEGEN, LE
    NUKLEARMEDIZIN, 1988, 27 (02) : 13 - 13
  • [2] PRELIMINARY NORMAL VALUES FOR THE TC-99M-MERCAPTOACETYLTRIGLYCINE (MAG3) CLEARANCE IN INFANTS
    GIRGENSOHN, SC
    SCHOFER, O
    BOCKISCH, A
    MEISINGER, C
    BEETZ, R
    HAHN, K
    NUC COMPACT-EUROPEAN-AMERICAN COMMUNICATIONS IN NUCLEAR MEDICINE, 1991, 22 (03): : 84 - 87
  • [3] Renal scintigraphy with Tc-99m-mercaptoacetyltriglycine (MAG(3)) in dogs and cats
    TassaniPrell, M
    Both, C
    Kostlin, R
    KLEINTIERPRAXIS, 1997, 42 (04): : 287 - +
  • [4] Evaluation of Tc-99m-mercaptoacetyltriglycine (MAG3)-biocytin as a new hepatobiliary agent in bilirubin-coinjected mice.
    Kim, MK
    Sidel, J
    Le, N
    Kim, LS
    Yoo, TM
    Barker, C
    Kobayashi, H
    Green, MV
    Carrasquillo, JA
    Paik, CH
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 181 - 181
  • [5] PRELIMINARY EVALUATION OF TC-99M MERCAPTOACETYLTRIGLYCINE (MAG3) AS A REPLACEMENT FOR I-131 OIH
    TAYLOR, A
    ESHIMA, D
    FRITZBERG, AR
    KASINA, S
    CHRISTIAN, PE
    JOURNAL OF NUCLEAR MEDICINE, 1986, 27 (04) : 571 - 572
  • [6] CAPTOPRIL RENAL SCINTIGRAPHY WITH TC-99M-MERCAPTOACETYLTRIGLYCINE (TC-99M-MAG3) FOR DETECTING RENAL-ARTERY STENOSIS
    DONDI, M
    AMERICAN JOURNAL OF HYPERTENSION, 1991, 4 (12) : S737 - S740
  • [7] VALUE OF THE PARTIAL BODY TIME-ACTIVITY-CURVE (PBTAC) FOR THE DETERMINATION OF RENAL-FUNCTION WITH TC-99M-MERCAPTOACETYLTRIGLYCINE (MAG3)
    KESKE, U
    DEBRANDPASSARD, A
    CORDES, M
    LANGER, M
    EICHSTADT, H
    FELIX, R
    NUC COMPACT-EUROPEAN-AMERICAN COMMUNICATIONS IN NUCLEAR MEDICINE, 1991, 22 (02): : 52 - 56
  • [8] Improved tumor targeting of glycolated anti-tac monoclonal antibody Fab fragment labeled with Tc-99m-mercaptoacetyltriglycine (MAG3).
    Kim, MK
    Jeong, HJ
    Kao, CHK
    Yao, TS
    Kim, IS
    Waldmann, TA
    Carrasquillo, JA
    Paik, CH
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 226P - 226P
  • [9] COMPARISON OF TC-99M MERCAPTOACETYLTRIGLYCINE (MAG3) AND OIH IN NORMAL SUBJECTS AND PATIENTS
    TAYLOR, A
    ESHIMA, D
    CHRISTIAN, PE
    FRITZBERG, AR
    KASINA, S
    JOURNAL OF NUCLEAR MEDICINE, 1986, 27 (06) : 962 - 962
  • [10] INVESTIGATION OF THE LABELING CHARACTERISTICS OF TC-99M-MERCAPTOACETYLTRIGLYCINE
    BORMANS, G
    CLEYNHENS, B
    ADRIAENS, P
    VANBILLOEN, H
    DEROO, M
    VERBRUGGEN, A
    NUCLEAR MEDICINE AND BIOLOGY, 1995, 22 (03): : 339 - 349
12345